ANVS
Annovis Bio, Inc.Company with tickers: ANVS
CIK
1477845
CUSIP
03615A108
Shares Outstanding
42,541,868
Price History
Institutional Holders
Short Volume
Short Interest
Fails to Deliver
Financials
SEC Filings
Earnings Calls
Insider Trades
Congressional Trades
| Line Item | Value | Unit | Period End | Form | Filed |
|---|---|---|---|---|---|
| Revenue | — | ||||
| Revenue (ASC 606) | $0 | USD | 2026-03-31 | 10-Q | 2026-05-15 |
| Cost of Revenue | — | ||||
| Gross Profit | — | ||||
| Operating Expenses | $6,282,681 | USD | 2025-03-31 | 10-Q | 2026-05-15 |
| Research & Development | $5,011,517 | USD | 2025-03-31 | 10-Q | 2026-05-15 |
| Operating Income | $-6,282,681 | USD | 2025-03-31 | 10-Q | 2026-05-15 |
| Net Income | $-5,537,069 | USD | 2025-03-31 | 10-Q | 2026-05-15 |
| EPS (Basic) | $-0.32 | USD/shares | 2025-03-31 | 10-Q | 2026-05-15 |
| EPS (Diluted) | $-0.32 | USD/shares | 2025-03-31 | 10-Q | 2026-05-15 |